Codexis Inc.

11.12-0.1000-0.89%Vol 1.03M1Y Perf -52.62%
Jun 28th, 2022 16:00 DELAYED
BID10.89 ASK11.40
Open11.24 Previous Close11.22
Pre-Market- After-Market11.12
 - -  - -%
Target Price
32.29 
Analyst Rating
Strong Buy 1.00
Potential %
190.38 
Finscreener Ranking
★★★★+     57.14
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★     51.08
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★+     53.15
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
8.88 
Earnings Rating
Sell
Market Cap726.18M 
Earnings Date
4th Aug 2022
Alpha0.01 Standard Deviation0.17
Beta1.97 

Today's Price Range

10.9211.46

52W Range

8.1142.01

5 Year PE Ratio Range

-57.60-38.90

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Sell
Performance
1 Week
19.87%
1 Month
1.54%
3 Months
-43.13%
6 Months
-64.95%
1 Year
-52.62%
3 Years
-39.12%
5 Years
115.77%
10 Years
206.56%

TickerPriceChg.Chg.%
CDXS11.12-0.1000-0.89
AAPL137.44-4.2200-2.98
GOOG2 251.43-81.0200-3.47
MSFT256.48-8.4100-3.17
XOM91.502.47002.77
WFC40.18-0.0600-0.15
JNJ176.94-5.1800-2.84
FB196.640.99000.51
GE65.88-0.8300-1.24
JPM115.82-0.5600-0.48
Financial StrengthValueIndustryS&P 500US Markets
4.70
4.90
0.21
0.30
-
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
78.30
-18.00
-12.20
-31.40
-16.99
RevenueValueIndustryS&P 500US Markets
122.06M
1.87
18.71
16.07
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.18-0.1327.78
Q04 2021-0.18-0.1611.11
Q03 2021-0.090.03133.33
Q02 2021-0.17-0.0758.82
Q01 2021-0.20-0.1430.00
Q04 2020-0.13-0.0653.85
Q03 2020-0.16-0.1037.50
Q02 2020-0.25-0.1156.00
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.12-9.09Negative
9/2022 QR-0.14-16.67Negative
12/2022 FY-0.418.89Positive
12/2023 FY-0.36-63.64Negative
Next Report Date4th Aug 2022
Estimated EPS Next Report-0.12
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume1.03M
Shares Outstanding65.30K
Shares Float56.70M
Trades Count15.42K
Dollar Volume11.46M
Avg. Volume760.65K
Avg. Weekly Volume764.71K
Avg. Monthly Volume746.92K
Avg. Quarterly Volume770.31K

Codexis Inc. (NASDAQ: CDXS) stock closed at 11.22 per share at the end of the most recent trading day (a -1.92% change compared to the prior day closing price) with a volume of 861.68K shares and market capitalization of 726.18M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 161 people. Codexis Inc. CEO is John J. Nicols.

The one-year performance of Codexis Inc. stock is -52.62%, while year-to-date (YTD) performance is -64.12%. CDXS stock has a five-year performance of 115.77%. Its 52-week range is between 8.11 and 42.01, which gives CDXS stock a 52-week price range ratio of 8.88%

Codexis Inc. currently has a PE ratio of -34.70, a price-to-book (PB) ratio of 4.71, a price-to-sale (PS) ratio of 6.00, a price to cashflow ratio of 1 242.70, a PEG ratio of 2.32, a ROA of -9.44%, a ROC of -10.54% and a ROE of -13.13%. The company’s profit margin is -16.99%, its EBITDA margin is -12.20%, and its revenue ttm is $122.06 Million , which makes it $1.87 revenue per share.

Of the last four earnings reports from Codexis Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.12 for the next earnings report. Codexis Inc.’s next earnings report date is 04th Aug 2022.

The consensus rating of Wall Street analysts for Codexis Inc. is Strong Buy (1), with a target price of $32.29, which is +190.38% compared to the current price. The earnings rating for Codexis Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Codexis Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Codexis Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 20.31, ATR14 : 0.79, CCI20 : 137.56, Chaikin Money Flow : 0.10, MACD : -0.27, Money Flow Index : 70.63, ROC : 8.83, RSI : 56.71, STOCH (14,3) : 89.63, STOCH RSI : 0.93, UO : 64.93, Williams %R : -10.37), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Codexis Inc. in the last 12-months were: Bernard J. Kelley (Sold 20 000 shares of value $72 400 ), Bernard J. Kelley (Sold 20 000 shares of value $516 820 ), Byron Dorgan (Option Excercise at a value of $72 400), Byron Dorgan (Sold 20 000 shares of value $558 862 ), Dennis P. Wolf (Sold 10 000 shares of value $251 763 ), John J. Nicols (Option Excercise at a value of $809 900), John J. Nicols (Sold 297 500 shares of value $6 846 274 ), Patrick Y. Yang (Sold 16 000 shares of value $387 125 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (100.00 %)
7 (100.00 %)
6 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Codexis Inc.

Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins and developing biocatalyst products. The firm's products and services include Screening and Evolution services, Enzymes, Screening Kits. It also develops protein engineering and biocatalyst platforms such as Codeevolver, Ketoreductases, Transminases, Imine reductases etc. The company operates in two business segment namely Performance Enzymes and Novel Biotherapeutics.

CEO: John J. Nicols

Telephone: +1 650 421-8100

Address: 200 Penobscot Drive, Redwood City 94063, CA, US

Number of employees: 161

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

47%53%

Bearish Bullish

56%44%

Bearish Bullish

55%45%

TipRanks News for CDXS

Mon, 09 May 2022 10:26 GMT Codexis (CDXS) Gets a Buy Rating from H.C. Wainwright

- TipRanks. All rights reserved.

News

Stocktwits